A New Journey Against Brain Disorders Begins

• 

  Research Capabilities

  Our clinical and preclinical research platforms include therapeutic interventions, access to rare diseased populations, extensive molecular and neurophysiological (EEG) biomarker capabilities, preclinical pharmacological and transgenic models, a large panel of behavioural analysis, in-vitro rodent and human iPSC assays.
• 

  Ethical Compliance

  We are committed to highest ethical scientific practice for both our clinical and preclinical studies. Our clinical biomarker studies are ethically reviewed and performed by specialised trained staff. Animal studies respect animal welfare and the proper implementation of the 3Rs.
• 

  Think Rare

  Rare is many. We encourage everyone to #ThinkRare by increasing awareness of rare diseases. We work with multiple members of the amazing rare disease communities to carry out research that matters and puts patients’ needs first.